These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19367873)

  • 1. Acute nutrition management in the prevention of metabolic illness: a practical approach with glucose polymers.
    Van Hove JL; Myers S; Kerckhove KV; Freehauf C; Bernstein L
    Mol Genet Metab; 2009 May; 97(1):1-3. PubMed ID: 19367873
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective review of anesthesia and perioperative care in children with medium-chain acyl-CoA dehydrogenase deficiency.
    Allen C; Perkins R; Schwahn B
    Paediatr Anaesth; 2017 Jan; 27(1):60-65. PubMed ID: 27896927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for inherited metabolic disease.
    Grosse SD; Dezateux C
    Lancet; 2007 Jan; 369(9555):5-6. PubMed ID: 17208621
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of urinary hexanoylglycine in the diagnosis of MCAD deficiency from newborn screening.
    Downing M; Manning NJ; Dalton RN; Krywawych S; Oerton J
    J Inherit Metab Dis; 2008 Aug; 31(4):550. PubMed ID: 18649007
    [No Abstract]   [Full Text] [Related]  

  • 5. Acyl-CoA dehydrogenase deficiency: varieties with neurological involvement.
    Gordon N
    Dev Med Child Neurol; 2005 Mar; 47(3):207-10. PubMed ID: 15739728
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.
    Tajima G; Sakura N; Yofune H; Nishimura Y; Ono H; Hasegawa Y; Hata I; Kimura M; Yamaguchi S; Shigematsu Y; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):122-30. PubMed ID: 16046200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-chain acyl-CoA dehydrogenase deficiency.
    Egidio RJ; Francis GL; Coates PM; Hale DE; Roesel A
    Am Fam Physician; 1989 May; 39(5):221-6. PubMed ID: 2718899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome.
    Derks TG; Reijngoud DJ; Waterham HR; Gerver WJ; van den Berg MP; Sauer PJ; Smit GP
    J Pediatr; 2006 May; 148(5):665-670. PubMed ID: 16737882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of expanded newborn screening at Boston children's hospital: benefits and challenges in defining true disease.
    Landau YE; Waisbren SE; Chan LM; Levy HL
    J Inherit Metab Dis; 2017 Mar; 40(2):209-218. PubMed ID: 28054209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
    Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
    Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-chain acyl-CoA dehydrogenase deficiency: a case presentation.
    Moore DJ
    Neonatal Netw; 2005; 24(5):7-13. PubMed ID: 16279050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
    Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
    Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disturbances in phosphate metabolism during parenteral alimentation. Hypophosphatemic syndrome].
    Deligne P
    Ann Anesthesiol Fr; 1977; 18(12):975-91. PubMed ID: 24396
    [No Abstract]   [Full Text] [Related]  

  • 15. Vacuolation of neutrophils and acanthocytosis in child with medium chain acyl-CoA dehydrogenase deficiency.
    Lainey E; Ogier H; Fenneteau O
    Br J Haematol; 2008 Mar; 140(6):595. PubMed ID: 18215202
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal therapy in the future: a kinetic problem.
    Crigler JF
    Aust Paediatr J; 1979 Mar; 15 Spec No():7-16. PubMed ID: 380552
    [No Abstract]   [Full Text] [Related]  

  • 17. Newborn screening for metabolic disorders.
    Waisbren SE
    JAMA; 2006 Aug; 296(8):993-5. PubMed ID: 16926360
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor.
    Krakoff IH; Murphy ML
    Pediatrics; 1968 Jan; 41(1):52-6. PubMed ID: 5635486
    [No Abstract]   [Full Text] [Related]  

  • 19. Anesthesia in a child with medium-chain Acyl-CoA dehydrogenase deficiency.
    Justiz AC; Mayhew JF
    Paediatr Anaesth; 2006 Dec; 16(12):1293-4. PubMed ID: 17121566
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening.
    Hsu HW; Zytkovicz TH; Comeau AM; Strauss AW; Marsden D; Shih VE; Grady GF; Eaton RB
    Pediatrics; 2008 May; 121(5):e1108-14. PubMed ID: 18450854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.